W 
WuXi AppTec Co 603259.SS · CNY
Health Care · Life Sciences Tools & Services · Shanghai · 🇨🇳 China
150.29
+2.24%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥45.46bn
FY2016FY2025
Net income
CN¥19.15bn
FY2016FY2025
Free cash flow
CN¥11.67bn
FY2016FY2025
Shareholders' equity
CN¥79.71bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥45.46bn | CN¥33.58bn | CN¥34.52bn | CN¥39.35bn | CN¥22.90bn | CN¥16.54bn | CN¥12.87bn | CN¥9.61bn | CN¥7.77bn | CN¥5.23bn |
| Gross profit | CN¥21.65bn | CN¥13.93bn | CN¥14.19bn | CN¥14.68bn | CN¥8.31bn | CN¥6.28bn | CN¥5.01bn | CN¥3.79bn | CN¥3.25bn | CN¥2.13bn |
| Research and development | CN¥1.12bn | CN¥1.06bn | CN¥1.23bn | CN¥1.61bn | CN¥942.2m | CN¥693.3m | CN¥590.4m | CN¥436.5m | CN¥305.6m | CN¥183.5m |
| Operating income | CN¥17.00bn | CN¥9.91bn | CN¥10.16bn | CN¥10.65bn | CN¥6.04bn | CN¥3.39bn | CN¥2.34bn | CN¥2.58bn | CN¥1.64bn | CN¥1.20bn |
| Net income | CN¥19.15bn | CN¥8.09bn | CN¥8.22bn | CN¥8.81bn | CN¥5.10bn | CN¥2.96bn | CN¥1.85bn | CN¥2.26bn | CN¥1.23bn | CN¥834.4m |
| Diluted earnings per share | 7.98 | 2.79 | 2.74 | 2.84 | 1.64 | 1.06 | 0.67 | 0.92 | 0.55 | 0.35 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥103.12bn | CN¥80.33bn | CN¥73.67bn | CN¥64.69bn | CN¥55.13bn | CN¥46.29bn | CN¥29.24bn | CN¥22.67bn | CN¥12.58bn | CN¥9.06bn |
| Cash and short-term investments | CN¥40.94bn | CN¥19.56bn | CN¥14.56bn | CN¥7.99bn | CN¥8.77bn | CN¥14.85bn | CN¥6.92bn | CN¥7.88bn | CN¥2.48bn | CN¥2.52bn |
| Total liabilities | CN¥22.87bn | CN¥21.24bn | CN¥18.15bn | CN¥17.76bn | CN¥16.37bn | CN¥13.80bn | CN¥11.93bn | CN¥4.98bn | CN¥6.24bn | CN¥3.88bn |
| Debt | — | CN¥8.50bn | CN¥5.75bn | CN¥5.87bn | CN¥4.11bn | CN¥4.30bn | CN¥5.71bn | CN¥154.0m | CN¥1.62bn | CN¥493.0m |
| Shareholders' equity | CN¥79.71bn | CN¥58.63bn | CN¥55.12bn | CN¥46.59bn | CN¥38.49bn | CN¥32.49bn | CN¥17.31bn | CN¥17.69bn | CN¥6.34bn | CN¥4.77bn |
| Shares outstanding | 2,401m | 2,899m | 3,001m | 3,100m | 3,100m | 2,791m | 2,768m | 2,451m | 2,218m | 2,401m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | CN¥17.20bn | CN¥10.62bn | CN¥13.39bn | CN¥10.62bn | CN¥4.59bn | CN¥3.97bn | CN¥2.92bn | CN¥1.64bn | CN¥1.79bn | CN¥1.50bn |
| Capital spending | −CN¥5.54bn | −CN¥3.43bn | −CN¥5.52bn | −CN¥9.97bn | −CN¥6.94bn | −CN¥3.03bn | −CN¥2.53bn | −CN¥2.25bn | −CN¥1.36bn | −CN¥819.6m |
| Free cash flow | CN¥11.67bn | CN¥7.19bn | CN¥7.87bn | CN¥650.3m | −CN¥2.35bn | CN¥942.7m | CN¥384.2m | −CN¥608.5m | CN¥430.3m | CN¥683.9m |
| Dividends paid | −CN¥4.97bn | −CN¥2.64bn | −CN¥2.76bn | −CN¥1.60bn | −CN¥912.7m | −CN¥638.1m | −CN¥730.5m | −CN¥83.3m | −CN¥40.3m | −CN¥39.4m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥16.39bn | CN¥12.44bn | CN¥12.60bn | CN¥12.04bn | CN¥9.54bn | CN¥8.26bn | CN¥9.88bn | CN¥8.95bn |
| Gross profit | CN¥9.14bn | CN¥6.27bn | CN¥6.34bn | CN¥5.99bn | CN¥4.42bn | CN¥3.49bn | CN¥4.29bn | CN¥3.83bn |
| Operating income | CN¥7.74bn | CN¥5.61bn | CN¥4.99bn | CN¥4.62bn | CN¥4.83bn | CN¥3.67bn | CN¥3.16bn | CN¥2.41bn |
| Net income | CN¥6.38bn | CN¥4.65bn | CN¥7.08bn | CN¥3.52bn | CN¥4.18bn | CN¥3.14bn | CN¥2.50bn | CN¥1.96bn |
| Diluted earnings per share | 2.66 | 1.94 | 2.95 | 1.46 | 1.74 | 1.31 | 0.86 | 0.68 |
| Cash from operations | CN¥6.10bn | CN¥3.60bn | CN¥5.79bn | CN¥4.12bn | CN¥4.24bn | CN¥3.19bn | CN¥4.03bn | CN¥3.41bn |
| Capital spending | −CN¥1.77bn | −CN¥1.19bn | −CN¥1.97bn | −CN¥1.46bn | −CN¥1.37bn | −CN¥734.0m | −CN¥1.51bn | −CN¥981.0m |
| Free cash flow | CN¥4.34bn | CN¥2.40bn | CN¥3.82bn | CN¥2.66bn | CN¥2.87bn | CN¥2.46bn | CN¥2.52bn | CN¥2.43bn |
| Total assets | CN¥116.24bn | CN¥107.41bn | CN¥103.12bn | CN¥94.60bn | CN¥71.74bn | CN¥72.33bn | CN¥68.74bn | CN¥63.53bn |
| Cash and short-term investments | CN¥46.63bn | CN¥43.38bn | CN¥40.94bn | CN¥33.00bn | CN¥20.91bn | CN¥22.04bn | CN¥16.74bn | CN¥12.03bn |
| Debt | CN¥14.72bn | CN¥7.80bn | CN¥8.26bn | CN¥9.09bn | CN¥6.24bn | CN¥5.29bn | CN¥4.06bn | CN¥5.84bn |
| Shareholders' equity | CN¥83.32bn | CN¥84.22bn | CN¥79.71bn | CN¥70.95bn | CN¥51.27bn | CN¥53.35bn | CN¥50.18bn | CN¥47.22bn |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 4.9% | 22.4% | 25.0% |
| Operating income | 16.9% | 38.1% | 36.2% |
| Net income | 29.5% | 45.3% | 49.3% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 45.0% | 42.1% | 41.1% | 40.8% |
| Operating margin | 34.1% | 31.2% | 29.7% | 28.2% |
| Net margin | 34.5% | 29.0% | 27.2% | 25.3% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Price to earnings | 11.4 | 19.7 | 26.6 | 28.5 | 72.1 | 105.8 | 81.8 | 34.5 |
| Price to sales | 4.8 | 4.8 | 6.3 | 6.4 | 16.1 | 18.9 | 11.8 | 8.1 |
Dividends and splits
Per share, in the currency the company pays
Paid for 7 years. Last went ex-dividend on 4 Sept 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 2.089 | 1.682 | 0.99 | 0.893 | 0.517 | 0.303 | 0.201 | 0.247 |
- 6-for-5 split · 8 Jun 2021
- 7-for-5 split · 4 Jun 2020
- 7-for-5 split · 2 Jul 2019
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.